Machine Learning-Based Identification of Survival-Associated CpG Biomarkers in Pancreatic Ductal Adenocarcinoma
Zhang, B.; Zhang, Y.; Zhao, Y.
Show abstract
Pancreatic ductal adenocarcinoma (PDAC) is an exceptionally aggressive cancer with a 5-year survival rate of less than 10%, driven by late-stage diagnosis, limited treatment options, and a lack of reliable biomarkers for early detection and prognosis. In this study, we integrated DNA methylation data from TCGA and ICGC cohorts, categorizing samples based on survival time, and identified 684 differentially methylated CpG sites, along with 224 CpG biomarkers significantly associated with patient survival through statistical and machine learning-based analyses. We developed a random forest model to predict patient survival, achieving 85.2% accuracy for short-survival patients and 70.0% for long-survival patients in the validation set. External dataset validation further confirmed the models robustness and accuracy. De novo motif analysis of genomic regions surrounding the 224 CpG biomarkers identified TWIST1 and FOXA2 as key transcriptional regulators enriched in survival-associated CpG sites, linking their activity to patient survival outcomes. Collectively, our findings highlight valuable epigenetic biomarkers and provide a predictive model to assess PDAC risk levels post-surgery, offering the potential for improved patient stratification and personalized therapeutic strategies.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Deeper insights into long-term survival heterogeneity of Pancreatic Ductal Adenocarcinoma (PDAC) patients using integrative individual- and group-level transcriptome network analyses 94%
- Multi-omic signatures identify pan-cancer classes of tumors beyond tissue of origin. 94%
- Integrative Network Analysis of Differentially Methylated and Expressed Genes for Biomarker Identification in Leukemia 93%
Similar papers in this journal
- DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas (PanNECs) and pancreatic neuroendocrine tumors (PanNETs) 94%
- Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering 93%
- A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer 93%
Similar papers in this journal
- Deciphering the Role of Complement System Genes in Pancreatic Cancer Susceptibility and Prognosis 93%
- Pancreatic cancer prognosis is predicted by a novel ATAC-array technology for assessing chromatin accessibility 93%
- Single-Cell RNA Sequencing Reveals the Effects of Chemotherapy on Human Pancreatic Adenocarcinoma and its Tumor Microenvironment 93%
Similar papers in this journal
- Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in osteosarcoma 92%
- Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression 92%
- Comprehensive multimodal and multiomic profiling reveals epigenetic and transcriptional reprogramming in lung tumors 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.